Ixazomib–Thalidomide–Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma

por Ludwig, Heinz, Poenisch, Wolfram, Knop, Stefan, Egle, Alexander, Schreder, Martin, Lechner, Daniel, Hajek, Roman, Gunsilius, Eberhard, Krenosz, Karl Jochen, Petzer, Andreas, Weisel, Katja, Niederwieser, Dietger, Einsele, Hermann, Willenbacher, Wolfgang, Melchardt, Thomas, Greil, Richard, Zojer, Niklas
Publicado 2019

Reduced alpha diversity of the oral microbiome correlates with short progression‐free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib‐based the...

por Ludwig, Heinz, Hausmann, Bela, Schreder, Martin, Pönisch, Wolfram, Zojer, Niklas, Knop, Stefan, Gunsilius, Eberhard, Egle, Alexander, Petzer, Andreas, Einsele, Hermann, Hajek, Roman, Weisel, Katja, Krenosz, Karl Jochen, Lang, Alois, Lechner, Daniel, Greil, Richard, Berry, David
Publicado 2020